BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 45 filers reported holding BRIDGEBIO PHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $673 | – | 700,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 114,338,000 | $138,406,149 | 5.08% |
| Affinity Asset Advisors, LLC | 17,000,000 | $20,578,500 | 3.76% |
| Graham Capital Management, L.P. | 73,241,000 | $88,469,027 | 1.96% |
| 683 Capital Management, LLC | 14,750,000 | $17,820,655 | 1.46% |
| ARISTEIA CAPITAL, L.L.C. | 53,423,000 | $64,668,542 | 1.14% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,929,000 | $30,176,555 | 0.69% |
| LINDEN ADVISORS LP | 47,125,000 | $56,947,457 | 0.54% |
| MACKAY SHIELDS LLC | 14,449,000 | $17,490,515 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 4,751,000 | $5,727,331 | 0.43% |
| Weiss Asset Management LP | 7,000,000 | $8,461,051 | 0.40% |